Effect of combination therapy with amlodipine and candesartan on cardiovascular events in hypertensive patients with coronary artery disease: A subgroup analysis of the HIJ-CREATE study

被引：0
|
作者：
Yamiaguchi, J. -i. [1 ]
Kasanuki, H. [1 ]
Hagiwara, N. [1 ]
Sumiyoshi, T. [1 ]
Honda, T. [1 ]
Haze, K. [1 ]
Takagi, A. [1 ]
Nagashima, M. [1 ]
Kawana, M. [1 ]
Ogawa, H. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [21] Erratum: Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J study
    Takao Saruta
    Koichi Hayashi
    Toshio Ogihara
    Kazuwa Nakao
    Tsuguya Fukui
    Kohshiro Fukiyama
    Hypertension Research, 2009, 32 : 1157 - 1157
  • [22] Comparison between candesartan and amlodipine on incidence of cardiovascular events in elderly hypertensive patients: Subanalysis of the CASE-J study
    Ogihara, Toshio
    Nakao, Kazuwa
    Fukui, Tsuguya
    Fukiyama, Kohshiro
    Saruta, Takao
    JOURNAL OF HYPERTENSION, 2006, 24 : 372 - 372
  • [23] Comparison between candesartan and amlodipine on incidence of cardiovascular events in hypertensive patients with diabetes: Subanalysis of the CASE-J study
    Nakao, Kazuwa
    Ogihara, Toshio
    Fukui, Tsuguya
    Fukiyama, Kohshiro
    Saruta, Takao
    JOURNAL OF HYPERTENSION, 2006, 24 : 372 - 373
  • [24] Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)
    Kasanuki, Hiroshi
    Hagiwara, Nobuhisa
    Hosoda, Saichi
    Sumiyoshi, Tetsuya
    Honda, Takashi
    Haze, Kazuo
    Nagashima, Michitaka
    Yamaguchi, Jun-ichi
    Origasa, Hideki
    Urashima, Mitsuyoshi
    Ogawa, Hiroshi
    EUROPEAN HEART JOURNAL, 2009, 30 (10) : 1203 - 1212
  • [25] Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study
    Dezsi, Csaba Andras
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (05) : 1902 - 1909
  • [26] Effect of amlodipine and enalapril on cardiovascular events in normotensive coronary artery disease patients with concomitant statin use in the CAMELOT trial
    Baghdasarian, SB
    Thompson, PD
    Shi, H
    Thakker, KM
    Tuzcu, ME
    Nissen, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 310A - 310A
  • [27] Comparison between candesartan and amlodipine on incidence of cardiovascular events in hypertensive patients with organ complications: Subanalysis of the case-J study
    Saruta, Takao
    Nakao, Kazuwa
    Fukui, Tsuguya
    Fukiyama, Kohshiro
    Ogihara, Toshio
    JOURNAL OF HYPERTENSION, 2006, 24 : 97 - 97
  • [28] Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J study (vol 32, pg 505, 2009)
    Saruta, Takao
    Hayashi, Koichi
    Ogihara, Toshio
    Nakao, Kazuwa
    Fukui, Tsuguya
    Fukiyama, Kohshiro
    HYPERTENSION RESEARCH, 2009, 32 (12) : 1157 - 1157
  • [29] Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) Study
    Horinaka, Shigeo
    Yabe, Akihisa
    Yagi, Hiroshi
    Ishimitsu, Toshihiko
    Yamazaki, Tsutomu
    Suzuki, Shinya
    Kohro, Takahide
    Nagai, Ryozo
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (02): : 111 - 119
  • [30] Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease in The Japanese Coronary Artery Disease (JCAD) Study
    Horinaka, Shigeo
    Yabe, Akihisa
    Yagi, Hiroshi
    Ishimitsu, Toshihiko
    Yamazaki, Tsutomu
    Suzuki, Shinya
    Kohro, Takahide
    Nagai, Ryozo
    CIRCULATION JOURNAL, 2010, 74 (03) : 503 - 509
12345